Stockwinners Market Radar for February 09, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:04 EST Tellurian director sells $3.44M in common stock - In a regulatory filing, Tellurian disclosed that its director Charif Souki sold 1.79M shares of common stock on February 8th in a total transaction size of $3.44M.

20:01 EST Cathie Wood's ARK Investment bought 35.0K shares of CareDx today

19:50 EST CTS Corporation board approves new $50M buyback authorization - The Board of Directors of CTS Corporation approved a new share repurchase program that authorizes the company to repurchase up to $50M of its common stock, replacing the program authorized by the Board of Directors in May 2021.

18:51 EST Meta Platforms exec sells $4.45M in common stock - In a regulatory filing, Meta Platforms disclosed that its Chief Business Officer Marne Levine sold 23.3K shares of common stock on February 7th in a total transaction size of $4.45M.

18:34 EST Intapp director sells $8.5M in common stock - In a regulatory filing, Intapp disclosed that its director Charles Moran sold 253.7K shares of common stock on February 7th in a total transaction size of $8.5M.

18:32 EST Macom CEO sells $1.99M in common stock - In a regulatory filing, Macom disclosed that its CEO Stephen Daly sold 30K shares of common stock on February 7th in a total transaction size of $1.99M.

18:17 EST HCA Healthcare exec Berres sells 4,000 common shares - In a regulatory filing, HCA Healthcare chief HR officer Jennifer Berres disclosed the sale of 4,000 common shares of the company on February 7 at a price of $255.228 per share.

17:58 EST Micron to cut executive salaries by up to 20% - In a regulatory filing, Micron said, as part of the significant steps previously announced by management to reduce the costs and operating expenses of Micron Technology, on February 5, the Compensation Committee of Micron's Board of Directors approved a reduction of the annual base salaries of Micron's Chief Executive Officer, Chief Financial Officer, and other named executive officers by 20% for the Chief Executive Officer, 15% for each NEO that is an executive vice president, and 10% for the NEO that is a senior vice president, effective with the payroll period commencing February 5, and continuing at the reduced amount through the remainder of Micron's 2023 fiscal year. Bonuses for all NEOs have also been suspended for fiscal 2023. As a result of these actions, the reduction in fiscal 2023 target total cash compensation for each of Micron's NEOs ranges from 53% to 75%. On February 5, the Compensation Committee agreed to amend the severance agreements in place with Micron's Chief Executive Officer, Chief Financial Officer, and other NEOs, to provide that any severance benefits received pursuant to the agreements will be determined using the annual base salaries in effect immediately before the Reduction. Micron is also reducing base salaries among a broad group of its executive level employees. In addition, Micron's Board of Directors voluntarily reduced the cash compensation of the non-employee members of the Board by 20% effective with the next full non-executive director compensation period and continuing at the reduced amount through fiscal 2023.

17:42 EST One Stop Systems says CEO David Raun to step down, after successor appointed - One Stop Systems announced that its chief executive officer, David Raun, will be stepping down, effective upon the appointment of his successor. The company has not yet identified a candidate to fill the position, however it has retained an internationally recognized search firm to aid in this effort. Mr. Raun will continue to serve as a member of the company's Board of Directors.

17:34 EST Financial Strategies Acquisition extends termination date - Financial Strategies Acquisition Corp., a special purpose acquisition company, announced that its Board of Directors has approved an extension of the period of time available to the company to consummate an initial business combination by one month from February 14, 2023 to March 14, 2023, as permitted under the company's amended and restated certificate of incorporation, as amended. The purpose of the extension is to provide additional time for the company to complete an initial business combination. In connection with the extension, Temmelig Investor LLC, an affiliate of the Company's co-sponsors, has deposited $50,000 (representing approximately $0.081 per unredeemed share of Class A common stock issued in the Company's initial public offering) into the trust account established in connection with the Company's initial public offering pursuant to the Company's third drawdown upon an unsecured promissory note in the aggregate principal amount of $600,000 issued by the Company to the Lender on December 9, 2022. The promissory note bears no interest and is convertible at the option of the Lender upon the consummation of an initial business combination into private units of the Company identical to the private placement units issued at the time of the Company's initial public offering at a conversion price of $10.00 per private unit. The Board may elect to further extend the Termination Date on a monthly basis until December 14, 2023 upon the deposit of an additional $50,000 into the trust account per monthly extension.

17:31 EST Lyft says does not see another large insurance expense in Q1

17:23 EST Lyft plans to reduce stock-based compensation expense in 2024 - Says will "significantly cut costs" in 2024.

17:15 EST Ford discloses stake in Rivian Automotive falls to 1.15% - Ford (F) disclosed in a 13G regulatory filing, from earlier, that it currently owns 1.15% or 10,502,427 shares of Rivian (RIVN) stock down from $87M reported in May of 2022. The Fly notes that the sale comes a week after Ford reported a $7.3B write-down on its Rivian investment. Ford sold over 90M shares of Rivian in 2022, according to regulatory filings.

17:10 EST Cloudflare jumps 12% to $65.01 afterhours following Q4 results and guidance

17:08 EST Doximity falls 15% to $31.11 after Q3 results and below-consensus guidance

17:07 EST Phathom Pharmaceuticals falls 21% after announcing FDA complete response letter

17:03 EST Transocean to invest in Global Sea Mineral Resources - Transocean announced that one of its wholly owned subsidiaries has agreed to make an investment in Global Sea Mineral Resources NV in exchange for a non-controlling interest in the company. GSR is the deep-sea mineral exploratory division of DEME Group NV and is engaged in the development and exploration of deep-sea polymetallic nodules that contain metals critical to the growing renewable energy market, and is a leading developer of nodule collection technology. Transocean has agreed to contribute the stacked Ocean Rig Olympia for GSR's ongoing exploration work, as well as make a nominal cash investment. In addition, Transocean expects to contribute engineering services on an in-kind basis. GSR intends to convert the Olympia for a system integration test scheduled for 2025 to validate the technical and environmental feasibility of recovering polymetallic nodules in ultra-deepwater on a commercial scale. The technical challenges associated with the recovery of deep-sea polymetallic nodules offer an opportunity to combine Transocean's unique ultra-deepwater operating experience with GSR's proprietary technology in polymetallic nodule collection to deliver a commercially viable nodule recovery enterprise for GSR.

17:01 EST Allegion increases quarterly dividend 10% to 45c per share - Allegion declared a quarterly dividend of 45c per ordinary share of the company, representing a 10% increase from 2022. The dividend is payable on March 31 to shareholders of record on March 15.

17:00 EST Expedia says strong lodging demand has continued in 2023 - Says investing more in loyalty program. Says January was north of 20% in lodging. Says seeing step change as the company enters 2023. Says working in a good demand environment. Says growth has been pretty broad. Says average daily rates have been holding strong. Says gross bookings on a reported basis were up 3% in October, which was impacted by the hurricane up 7% in November and up 2% in December, which was impacted by the winter storms in the US., excluding the weather-related events growth versus 2019 for each month in Q4 reached high-single digits that accelerated to the quarter. Says in January, saw step change, where lodging gross bookings accelerated even further growing over 20% versus 2019. Says pleased to see strong lodging demand continued in FY23, including total lodging bookings for stays expected to occur in the first half of 2023, continuing to meaningfully outpace, 2019 and 2022 levels. Comments taken from Q4 earnings conference call.

16:52 EST Lyft falls 25% to $12.17 per share after Q4 results

16:47 EST Robert Half raises quarterly dividend to 48c from 43c per share - The cash dividend will be paid on March 15 to all shareholders of record as of February 24.

16:47 EST Otonomo Technologies and Urgently to merge into new mobility services company - Otonomo Technologies and Urgently, a U.S.-based leading provider of digital roadside and mobility assistance technology and services, have entered into a definitive agreement to merge in an all-stock transaction. As a result of the transaction, Urgently expects that its shares of common stock will be listed under the ticker symbol "ULY". Upon closing of the transaction, which has been approved by each company's board of directors, holders of Otonomo's ordinary shares will receive common stock of Urgently. Otonomo's shareholders and other equityholders will own, in the aggregate, approximately 33% of the combined company on a fully diluted basis, subject to the determination of the final exchange ratio pursuant to the terms set forth in the definitive agreement. The transaction is expected to close in Q3. Urgently and Otonomo equityholders will own approximately 67% and 33%, respectively, of the combined company on a fully diluted basis. Urgently's 2022 revenue is estimated at more than $185M, a 25% increase over Urgently's 2021 revenue; post-closing, Otonomo will be a wholly owned subsidiary of Urgently. Urgently investors include BMW i Ventures, Porsche Ventures, Jaguar Land Rover's InMotion Ventures, American Tire Distributors, Iron Gate Capital and Emerald Technology Ventures. Urgently and Otonomo have solutions operating in more than 26 countries, more than 100 partnership agreements across the automotive OEM, transportation and mapping, insurance, fleet and rental sectors. Upon the closing of the transaction, Matt Booth will be CEO and Tim Huffmyer will be CFO of the combined company. Ben Volkow will join the Board of Directors and will have an advisor role with the combined company.

16:36 EST Genasys announces contract with Aramco - Genasys announced a contract with Aramco for Genasys Emergency Management, or GEM, enterprise services. Genasys was awarded the contract by Aramco over other leading mass notification software providers as a result of a competitive bidding process.

16:32 EST Equifax to acquire Boa Vista Servicos for $596M - Equifax announced a definitive agreement to acquire Boa Vista Servicos, the second largest credit bureau in Brazil. The agreement was approved by the Boa Vista Servicos Board of Directors for R$8.00 per share, implying an estimated total enterprise value of $596M based on a USD/BRL exchange rate of 5.2033. This acquisition will expand Equifax's capabilities in the large and fast-growing Brazilian market and offers Boa Vista Servicos access to Equifax's expansive global capabilities and cloud-native data, products, decisioning and analytical technology for the rapid development of new products and services, and expansion into new industries. The initial Equifax offer to acquire Boa Vista Servicos was announced on December 19, 2022. The transaction is subject to Boa Vista Servicos's shareholder approval and other customary closing conditions and is expected to be completed sometime in the second quarter of 2023, at which time the company will become a subsidiary of Equifax Brasil. The acquisition is not anticipated to have a material impact on 2023 Equifax financial results.

16:30 EST Hyzon Motors to appeal Nasdaq listing determination - Hyzon Motors received a Staff Determination from the Listing Qualifications Staff of The Nasdaq Stock Market on February 3 notifying the company that, unless the company requests an appeal, trading of the company's Class A common stock and warrants will be suspended at the opening of business on February 14, and remove the company's securities from listing and registration on Nasdaq. By February 10, the company plans to appeal the Staff Determination and request a hearing before the Nasdaq Hearings Panel. A request for a hearing regarding a delinquent filing automatically stays the delisting process of the company's securities for a period of 15 days from the date of the request. However, the company intends to request a stay of the suspension of its securities pending the hearing which is typically scheduled to occur approximately 30-45 days after the date of the hearing request. The Staff Determination was issued because the company informed Nasdaq that it will not file its Quarterly Reports for the periods ended June 30, 2022 and September 30, 2022 on or before February 13. There can be no assurance that such reports will be filed before any hearing before the Hearings Panel, or that the Hearings Panel will grant the company's request for a stay pending the hearing. If the company's appeal to the Hearings Panel is denied, the company's securities will be subject to delisting on Nasdaq.

16:30 EST Eliem Therapeutics Inc trading resumes

16:28 EST Seneca Foods appoints Michael Wolcott CFO - Seneca Foods announced that it will appoint the current Vice President of Finance, Michael Wolcott, to Senior Vice President of Finance and Chief Financial Officer effective April 1 As CFO, Mr. Wolcott will oversee the Company's finance organization and be responsible for all financial and accounting matters, including tax, treasury, internal audit, and investor relations. Mr. Wolcott will also serve on the Company's executive management team and will be involved in the Company's corporate strategy and business development, including mergers & acquisitions, and capital transactions. Mr. Wolcott will report to the President and Chief Executive Officer, Paul Palmby. Mr. Wolcott will succeed the Company's current CFO, Tim Benjamin, who has announced his retirement as CFO effective March 31 Benjamin will remain with the Company until June 30 and provide transition assistance as needed.

16:26 EST RPT Realty raises quarterly dividend 8% to 14c per share - RPT Realty announced that its board of trustees declared a first quarter regular cash dividend of 14c per common share, representing an increase of 8% over the prior quarterly rate. The board of trustees also approved a first quarter Series D convertible preferred share dividend of $0.90625 per share. The dividends for the period January 1 through March 31 are payable on April 3, 2023 for shareholders of record on March 20, 2023

16:23 EST Invesco reports preliminary AUM $1.48T as of January 31 - An increase of 5.2% versus previous month-end. The firm experienced net long-term outflows of $0.1B in the month.

16:22 EST Virtus Investment reports January-end AUM of $157.8B - Virtus Investment Partners reported preliminary assets under management of $157.8 billion as of January 31, 2023. In addition, the company provided services to $2.6 billion of other fee-earning assets, which are not included in assets under management.

16:21 EST Adecoagro names Emilio Federico Gnecco as CFO - Adecoagro announced the appointment of Emilio Federico Gnecco as CFO of the company. Gnecco's appointment became effective as of February 8, and he succeeds Carlos Alberto Boero Hughes, who has decided to take on new personal and professional endeavors. Gnecco has held the position of Chief Legal Officer of the company since 2005.

16:20 EST PayPal CEO Dan Schulman to retire at year-end

16:18 EST Genasys backs FY23 outlook - Danforth concluded, "We are reiterating our fiscal 2023 outlook for continued revenue growth with stronger international sales, continuing LRAD deliveries to the U.S. military, increasing software services sales, and significant SaaS revenue growth."

16:11 EST Eliem to re-prioritize pipeline, reduce workforce by 55% in 1H23 - As part of the reorganization, the company will reduce its workforce by approximately 55% in the first half of 2023.The Company will continue its focus on treatments for neuronal excitability disorders, and is retaining its core R&D team, led by Dr. Valerie Morisset, EVP R&D and Chief Scientific Officer. This team will carry on driving ETX-123 development forward and executing on other pipeline opportunities, including other opportunities for the Kv7 Program.

16:09 EST Qualys announces $100M increase to share repurchase program

16:07 EST Warrior Met Coal raises dividend 17% to 7c per share - The dividend is payable on February 27, 2023, to stockholders of record as of the close of business on February 20, 2023.

16:05 EST Athena Consumer Acquisition to transfer listing to NYSE American - Athena Consumer Acquisition announced that it will transfer its listing from the New York Stock Exchange to the NYSE American. Athena received written confirmation that it has been cleared to file an initial listing application with the NYSE American on February 6 and received the final approval for listing from the staff of NYSE American on February 9.

16:00 EST Eliem Therapeutics Inc trading halted, news pending

15:34 EST Crypto exchange Kraken shutters staking program in $30M SEC deal - The Securities and Exchange Commission charged Payward Ventures, and Payward Trading, both commonly known as Kraken, with failing to register the offer and sale of their crypto asset staking-as-a-service program, whereby investors transfer crypto assets to Kraken for staking in exchange for advertised annual investment returns of as much as 21%.To settle the SEC's charges, the two Kraken entities agreed to immediately cease offering or selling securities through crypto asset staking services or staking programs and pay $30M in disgorgement, prejudgment interest, and civil penalties. According to the SEC's complaint, since 2019, Kraken has offered and sold its crypto asset "staking services" to the general public, whereby Kraken pools certain crypto assets transferred by investors and stakes them on behalf of those investors. Staking is a process in which investors lock up - or "stake" - their crypto tokens with a blockchain validator with the goal of being rewarded with new tokens when their staked crypto tokens become part of the process for validating data for the blockchain. When investors provide tokens to staking-as-a-service providers, they lose control of those tokens and take on risks associated with those platforms, with very little protection. The complaint alleges that Kraken touts that its staking investment program offers an easy-to-use platform and benefits that derive from Kraken's efforts on behalf of investors, including Kraken's strategies to obtain regular investment returns and payouts "Whether it's through staking-as-a-service, lending, or other means, crypto intermediaries, when offering investment contracts in exchange for investors' tokens, need to provide the proper disclosures and safeguards required by our securities laws," said SEC Chair Gary Gensler. "Today's action should make clear to the marketplace that staking-as-a-service providers must register and provide full, fair, and truthful disclosure and investor protection." Publicly traded companies in the space include Bit Digital (BTBT), Coinbase (COIN), Core Scientific (CORZ), Greenidge Generation (GREE), Marathon Digital (MARA), MicroStrategy (MSTR), Riot Blockchain (RIOT), Stronghold Digital Mining (SDIG) and TeraWulf (WULF). Reference Link

14:51 EST Stellantis' Ram confirms first electric pickup to be known as 'Ram 1500 REV' - Ram Truck brand, part of the portfolio of brands offered by automaker and mobility provider Stellantis, confirmed that its first battery-electric pickup truck will be known as the Ram 1500 REV. "At Ram, we started a revolution last year as we invited consumers along on the beginning of our electrification journey, gathering their feedback on exactly what they are looking for in an electric pickup truck. We look forward to delivering our first EV pickup - the all-new Ram 1500 REV - to those consumers next year. We are confident the Ram 1500 REV will push past the competition, offering what will be the leading combination of attributes customers care about the most: range, payload, towing and charge time," said Mike Koval Jr., Ram brand CEO - Stellantis. "Production of the all-new Ram 1500 REV will begin next year. More information will be available Sunday, Feb. 12, and the vehicle will be formally revealed to the public in the coming months," the company added.

14:29 EST Genius Group LTD trading resumes

13:29 EST Enveric made up a lot of ground during pandemic, CEO tells The Fly

13:29 EST Enveric CEO sees 'very significant' market opportunity for anxiety treatments

13:08 EST Disney announces details of strategic restructuring - The Walt Disney Company has announced details of its strategic restructuring, initially discussed on last night's earnings call, stating that its plan "will refocus the organization on creativity, empower creative leaders and ensure they are accountable for all aspects of their businesses globally, and put the company's streaming business on a path to sustained growth and profitability." Effective immediately, the company will be organized into three core business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences and Products. "The leaders of each business segment will have full operational control and financial responsibility for creative development, marketing, technology, sales, and distribution, and will be accountable for driving business efficiencies globally," Disney said in a press release. Disney Entertainment will be co-chaired by Alan Bergman and Dana Walden who will be responsible for the company's full portfolio of entertainment media and content businesses globally, including streaming. ESPN will include ESPN networks and ESPN+ and will be led by Jimmy Pitaro. Pitaro will also be responsible for the management and supervision of the company's full portfolio of sports content, products and experiences across all of Disney's platforms worldwide, including its international sports channels. Effective immediately, several shared-service organizations across the company will support both Disney Entertainment and ESPN, facilitating company-wide efficiencies and creating a more cost-effective, coordinated, and streamlined approach to operations. These include Product and Technology, led by Aaron LaBerge; Advertising Sales, led by Rita Ferro; and Platform Distribution led by Justin Connolly excluding Theatrical Distribution and Music, which will be overseen by Bergman. Outside of North America, the company's media, entertainment, and sports content and operations will continue to be managed regionally by Luke Kang, President Asia Pacific; Jan Koeppen, President EMEA; Diego Lerner, President LATAM; and K Madhavan, President India. These leaders will report to Bergman, Walden, and Pitaro as part of their global responsibilities. As a result of the changes, Rebecca Campbell, Chairman, International Content and Operations, has decided to leave the company. Campbell will stay on through June to help with the transition. Disney Parks, Experiences and Products - encompassing the company's award-winning theme parks, cruise line, resort destinations and Adventures by Disney and National Geographic Expeditions, as well as Disney's global consumer products, games, and publishing businesses - will continue under the leadership of Chairman Josh D'Amaro. The organizational changes will be implemented immediately, and the company will begin reporting financial results under the new business structure by the end of the fiscal year.

13:04 EST Treace Medical presents updated ALIGN3D interim data - Treace Medical Concept announced it will highlight new interim clinical data from the ALIGN3D study, and recent product innovations, at the 2023 American College of Foot and Ankle Surgeons Annual Scientific Conference in Los Angeles, California. The scientific poster titled, "Three Year Interim Analysis of a Five-Year Multicenter Study Assessing Radiographic and Patient Outcomes Following Triplanar Tarsometatarsal Arthrodesis with Early Weightbearing", includes an interim analysis of 128 patients from the ALIGN3D study with at least 24 months of follow-up following the Lapiplasty Procedure demonstrating: Early return to weight bearing in a walking boot at an average 8.1 days; 99.1% maintenance of correction in radiographic measures of 3-dimensional bunion correction at 24 months and a recurrence rate of 0.9%; 80.8% reduction in pain measured using the Visual Analog Scale at 24 months; 92% and 90% improvement in walking/standing and social interaction patient-reported quality of life measures, respectively, using the Manchester-Oxford Foot Questionnaire through 36 months; and 97.3% of patients reporting they were satisfied or very satisfied with overall results of the procedure at 36 months.

12:17 EST Canadian Pacific, United Steelworkers Local 1976 reach tentative agreement - Canadian Pacific announced it has reached a tentative collective agreement with the United Steelworkers Local 1976 covering approximately 550 administrative support and intermodal employees in Canada. "By working collaboratively with our valued union partners, we've reached another negotiated tentative agreement this year," said Keith Creel, CP's President and CEO. "We thank the United Steelworkers for working collaboratively with us throughout this negotiation. This tentative agreement is a testament to the hard work and commitment of both sides." CP has successfully negotiated three tentative collective agreements with its unions in 2023. Details of the USW tentative collective agreement will not be released publicly until the agreement has been ratified.

12:00 EST IFF falls -15.7% - IFF is down -15.7%, or -$17.65 to $94.79.

12:00 EST Maximus rises 11.5% - Maximus is up 11.5%, or $8.72 to $84.30.

12:00 EST DHT Holdings rises 13.5% - DHT Holdings is up 13.5%, or $1.23 to $10.36.

11:34 EST Brinker appoints James Butler as SVP, CSCO - Brinker International announced James Butler has joined the company as Senior Vice President and Chief Supply Chain Officer. In his new role, Butler oversees all supply chain functions, including procurement, food safety and quality assurance, distribution and logistics, brand program management and supply chain systems for Brinker's corporate-owned restaurants. Prior to joining the Brinker family, Butler was Senior Vice President, KFC Supply Chain, at Restaurant Supply Chain Solutions

10:36 EST Annaly Capital expects to reduce quarterly dividend in Q1 - On its Q4 earnings conference call, Annaly Capital said it expects to reduce its quarterly dividend in the first quarter 2023 to a level closer to historical yield on book value of 11%-2%, which compares to the approximately 16% yield on book it is currently paying. Annaly said it believes the decision allows it to appropriately manage the portfolio within conservative risk parameters.

10:13 EST MICT, Inc. enters corporate transaction for 100% ownership of Tingo Foods - MICT, Inc. has entered into a corporate transaction giving it ownership of 100% of Tingo Foods, which has developed a food processing business with a current capacity to process and wholesale more than $1B of food produce per annum. Through a joint venture, Tingo Foods has also committed to build and operate a $1.6B food processing facility in the Delta State of Nigeria. With build, fitout and commissioning scheduled for completion by the end of the first half of 2024, the new facility is expected to multiply the size of the Company's processing capacity and revenues, while also materially expanding its capacity for the offtake of produce from its farmers and increasing its supply into MICT's commodity trading platform and export business. Tingo Foods currently has the ability to produce and wholesale processed foods such as rice, millet, pasta and noodles. The range and volume of products will then increase considerably upon the launch of the new processing facility to also include tea, coffee, chocolate, biscuits, cooking oils, non-dairy milks, carbonated drinks, and mineral water, among others. Having been established and developed to date by Dozy Mmobuosi as a standalone business, Tingo Foods generated revenue of over $400M between its launch in September 2022 and December 31, 2022 and has an existing stock of processed food products with a cost value estimated at $204M. With the completion of the Tingo Mobile Limited acquisition completed on November 30, 2022, and as intended, MICT is now able to bring Tingo Foods into the group, vertically expand the group's agricultural footprint, and enhance its further growth and development. As part of the corporate transaction to transfer the ownership of Tingo Foods into MICT as a wholly owned subsidiary, the Company will pay consideration equal to the cost value of the stock on hand, which will be satisfied by the issuance of a long-term promissory note. The Tingo Foods transaction will not result in any new issuance of MICT common stock, nor of any instruments convertible into shares of the Company.

10:06 EST Allurion to become publicly listed via Compute Health combination - Allurion Technologies and Compute Health Acquisition entered into a definitive business combination agreement that will result in Allurion becoming a publicly listed company. Upon closing, the combined company will be named Allurion Technologies, Inc. and its common stock is expected to be traded on the New York Stock Exchange under the symbol "ALUR". Allurion is offering the world's first full-stack weight loss platform. At the core of this platform is The Allurion Program, which combines the world's first and only swallowable, procedure-less intragastric balloon for weight loss, a proprietary behavior change program, and the Virtual Care Suite, an artificial intelligence-powered digital therapeutic and remote patient monitoring solution. The Allurion Balloon is designed to address various shortcomings of legacy gastric balloons. It is swallowed as a capsule and filled under the guidance of a health care provider without surgery, endoscopy, or anesthesia. Allurion's revenue growth has been fueled by increasing utilization of The Allurion Program by existing providers and rapid geographical expansion. Allurion's revenues in 2020, 2021, and 2022 were $20 million, $38 million, and $64 million, respectively. In 2022, the Company continued its worldwide expansion with the launch of the Allurion Program in Canada, Mexico, India, Australia, and Brazil. In the U.S., Allurion has launched the AUDACITY trial, an open-label, pivotal study to evaluate the safety and efficacy of the Allurion Balloon plus Moderate Intensity Lifestyle Modification Therapy Program versus MILMTP alone in U.S. patients. The proposed transaction includes a fully committed PIPE led by RTW Investments and a non-dilutive, synthetic royalty financing from RTW Investments that will close concurrently with the business combination. The Company will continue to be led by Dr. Shantanu Gaur, Allurion's Co-Founder and CEO, after the business combination. The expanded Board of Directors is expected to be co-chaired by longtime Allurion investor Krishna Gupta of REMUS Capital and Omar Ishrak and include Nick Lewin, Chairman of Establishment Labs. The proposed transaction also includes a senior secured term loan from an affiliate of Fortress Investment Group to refinance existing Allurion debt and further extend runway, and is further supported by a $100M Chardan Equity Facility. Under the terms of the ChEF, after the proposed business combination has closed, Chardan Capital Markets has committed to purchase up to an aggregate of $100 million of Allurion common stock from time to time at the request of Allurion. This facility will provide Allurion with the ability to raise additional capital opportunistically in the future. Upon the closing of the proposed transaction, it is expected that the Company will issue, and assume warrants and other equity incentive arrangements representing or underlying, in the aggregate, 37,812,000 shares of the Company to Allurion equityholders, with the consideration payable to Allurion equityholders based on an assumed $500 million pro forma enterprise value of the combined Company. The proposed transaction also includes a minimum cash condition of $70 million and is expected to provide a minimum of $87 million of gross cash proceeds. In connection with the proposed transaction, holders of Compute Health Class A common stock will have the right to redeem their Compute Health Class A shares. If holders of Compute Health Class A common stock elect not to redeem their Compute Health Class A shares in connection with the proposed transaction, such holders will receive, at the closing of the proposed transaction, an additional 0.420455 shares of the Company for each non-redeemed share of Compute Health Class A common stock. The proposed transaction has been approved by the boards of directors of each of Compute Health and Allurion. The proposed transaction will require the approval of the stockholders of each of Compute Health and Allurion and is subject to other customary closing conditions, including the receipt of certain regulatory approvals and a registration statement on Form S-4 being declared effective by the Securities and Exchange Commission. The proposed transaction is expected to close in the first half of 2023.

10:00 EST Kellogg sees FY23 tax rate 22% - Says navigated through bottlenecks and shortages. Says snacks business should see sustained momentum. Says input cost inflation remains high. Says decided to retain plant based food business. Sees FY23 tax rate 22%. Sees FY23 operating profit up 7%-9%. Sees FY23 free cash flow $1B-$1.1B. Says expects momentum to continue into 2023. Says Kellogg Europe remains in good condition. Comments and guidance taken from Q4 earnings conference call.

10:00 EST Globus Medical falls -14.5% - Globus Medical is down -14.5%, or -$11.19 to $65.77.

10:00 EST Eneti rises 13.4% - Eneti is up 13.4%, or $1.32 to $11.14.

09:59 EST AbbVie says 'high level of confidence' in achieving FY23 guidance

09:50 EST Nelson Peltz says 'proxy fight is over' with Disney after last night's report - Trian Partners' Nelson Peltz says his "proxy fight is over" with Disney following last night's earnings report and other announcements regarding restructuring from the company, calling the results and CEO Bob Iger's plans a "huge win" for Disney shareholders. Peltz made the comments while being interviewed on CNBC regarding last night's report from Disney.

09:47 EST IFF falls -9.2% - IFF is down -9.2%, or -$10.40 to $102.04.

09:47 EST Globus Medical falls -14.9% - Globus Medical is down -14.9%, or -$11.46 to $65.50.

09:47 EST Gates Industrial rises 10.0% - Gates Industrial is up 10.0%, or $1.31 to $14.44.

09:46 EST Dragonfly Energy Holdings Corp trading halted, volatility trading pause

09:39 EST Disney CEO Iger: 'My preference' is to stay for two years - CEO Bob Iger told CNBC that former CEO Bob Chapek's structure was "a mistake" and created a "huge divide."

09:37 EST Dick's Sporting plans for over 200 SidelineSwap trade-in events in 1H23 - DICK'S Sporting Goods and SidelineSwap, are building on the success of the 60 trade-in events they executed in 2022, and are expanding their partnership to offer a series of 200 trade-in events in nineteen states through the first half of 2023.

09:35 EST Tech Target trading resumes

09:33 EST SolarEdge, Freedom Forever announce multiyear agreement - SolarEdge Technologies announced that it entered into a multiyear agreement with Freedom Forever, a U.S. residential solar installer, for the supply of residential smart energy products and solutions. As part of the multiyear agreement between the companies, Freedom Forever will offer its customers the SolarEdge Home Smart Energy Ecosystem, including the SolarEdge Home Hub Inverter, SolarEdge Power Optimizers, SolarEdge Home Battery, Backup Interface, Smart Energy Devices such as the SolarEdge EV Charger and Load Controllers.

09:31 EST Sumo Logic to be acquired by Francisco Partners for $1.7B

09:30 EST Tech Target trading halted, volatility trading pause

09:28 EST GitLab drops 5% to $46.90 after job cuts, MoffettNathanson comments

09:25 EST Ault, Ecoark in share pact that provides for BitNile.com acquisition by Ecoark - Ault Alliance (AULT) and Ecoark Holdings (ZEST) announced that they have entered into a share exchange agreement whereby, upon closing, Ecoark will acquire 100% of the outstanding equity of Ault Alliance's subsidiary BitNile.com. BitNile.com's metaverse platform will launch on March 1 representing an evolution of how people interact digitally with a bidirectional connection to the physical. The Platform will incentivize users through a tiered rewards system supported by a revenue and reward model. The Platform will be device-agnostic, where users will be able to play 3D immersive games, can purchase both digital and physical products, experience various forms of entertainment, and engage with a new social networking community across any of their internet connected devices. The Platform will allow users to participate in the metaverse with unique avatars and customized skins.At the closing of the Agreement, Ecoark will acquire BitNile.com from Ault Alliance and other founders, in exchange for shares of Ecoark preferred stock. The Preferred Stock will have a stated value of $100 million, be convertible into shares of Ecoark common stock, accrue dividends of 5% per annum for 10 years, and be entitled to certain other rights as set forth in the certificate of designation for the Preferred Stock. The closing of the Agreement, pursuant to which Ault Alliance will be able to convert and vote up to 19.9% of Ecoark's issued and outstanding shares of common stock, is subject to Ecoark's receipt of a fairness opinion, each parties' satisfaction of its due diligence review of the other party, completion of required stock exchange and regulatory approvals, and other customary closing conditions. The parties expect to complete the acquisition of BitNile.com during February .

09:21 EST Alkaline Water enters distribution partnership with Intrastate Distributors - Alkaline Water announced that Alkaline88 has partnered with Intrastate Distributors as a direct-store-delivery partner to market, sell, and distribute Alkaline88 products throughout five Michigan counties-Wayne, Monroe, Macomb, Oakland, and Washtenaw.

09:19 EST GitLab to reduce size of team by 7% - GitLab CEO Sid Sijbrandij sent a note to GitLab team members that the company posted on its investor relations site. The note reads in part: "I have made the decision to reduce the size of our team by 7%. This was a very difficult decision, and I understand this may be unexpected to some of you. I'd like to give some context about how we arrived at this outcome. The current macroeconomic environment is tough, and as a result, companies are still spending but they are taking a more conservative approach to software investments and are taking more time to make purchasing decisions. I had hoped reprioritizing our spending would be enough to withstand the growing global economic downturn. Unfortunately, we need to take further steps and match our pace of spending with our commitment to responsible growth." Reference Link

09:15 EST Ault Inc. trading resumes

09:11 EST Focus Universal hires ShareIntel to probe naked short selling activity - Focus Universal has hired Shareholder Intelligence Services to assist in efforts to help identify and combat suspected illegal naked short selling activities and market manipulation. This is all part of a larger set of action plans and resolutions approved by the management and board to address what might be a pervasive pattern of illegal short selling of its stock. This action plan may include pursuing potential legal actions together with other parties in the discovery and prosecution of persons engaging in market manipulation or illegal naked short selling. The company has authorized the following actions: Issuing a special dividend to all shareholders, which management believes may help to expose those who may have participated in market manipulation relating to the Company's shares. Focus Universal management believes it is in our long term shareholders' interest to continue to reward legitimate long term shareholders aligned with company goals. Investigating and pursuing any illegal market manipulation which may also include spreading negligently false or misleading information, such as blatantly false familial relationships within management and false auditor relationships to create shock value that will spread throughout social media. The company continues to hold that manipulation of stock through illegal activity should not be rewarded, and our legal team will investigate and take necessary actions. Advancing to the next stage of the legal process, and explore taking legal and regulatory action against anyone reasonably believed to be involved or suspected of being involved in any type of market manipulation relating to the Company's shares, including the exploration and steps toward joining the SEC Whistleblower Program.

09:09 EST Crexendo cloud communication platform surpasses 3M users - Crexendo announced that its cloud communication platform now supports over three million end users globally.

09:08 EST Disney's Illusion Island 2D video game to debut for Nintendo Switch on July 28 - "Embark on a brand-new adventure with Disney (DIS) Mickey Mouse's triumphant return to video games - and this time he's bringing a few friends! ..Disney, in collaboration with developer Dlala Studios, revealed that Disney Illusion Island, an upcoming local cooperative 2D platform adventure video game for up to four players, will debut exclusively for Nintendo Switch on July 28 . Additionally, pre-orders for Disney Illusion Island are available for $39.99 in Nintendo (NTDOY) eShop and at retail..."Fans are in for a treat with the upcoming launch of the whimsical cartoon-like experience offered by Disney Illusion Island," said Luigi Priore, VP, Disney, Pixar and 20th Century Games. "We're thrilled to work with developer Dlala Studios as they expand upon the Mickey & Friends world with a new and original storyline, engaging gameplay and delightful hand-drawn art style." said the company, in-part, in an earlier statement.

09:07 EST Verisk Analytics remains Hyundai's exclusive provider of telematics data - Hyundai Motor America, the U.S. distributor for global automaker Hyundai Motor Company (HYMTF), and Verisk (VRSK) have renewed an agreement in which Verisk will analyze telematics data from consenting owners of Hyundai and Genesis vehicles. Verisk will also continue to be the exclusive provider of that data to auto insurers. With Verisk's robust insurance analytics and experience as a technology provider, insurers will be able to access the data from the Verisk Data Exchange and price the policies of applicable Hyundai and Genesis owners based on the relative safety of their driving. "Verisk has proven itself as a critical partner in bringing our connected vehicle data to the insurance market and generating value for Hyundai and our customers," said Manish Mehrotra, executive director of digital business planning and connected operations at Hyundai. "Their advanced analytics and deep understanding of the diverse needs of insurers have enabled us to grow our usage-based insurance (UBI) program and better serve our customers. We look forward to exploring additional benefits resulting from next-generation analytics to evaluate better driving behaviors."

09:05 EST Cemtrex regains compliance with Nasdaq listing requirements - Cemtrex received notice from the Nasdaq Stock Market on February 8, 2023 informing the Company that it's common stock has regained full compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Cemtrex previously received a notification letter from the Listing Qualifications Department of Nasdaq on January 26, 2023 notifying the Company that it has not regained compliance with Listing Rule 5550(a)(2) and accordingly would be delisted from the Capital Market. Cemtrex, however, was granted an additional 180 days, or until July 24, 2023, to regain compliance with the Minimum Bid Price Requirement, a requirement which Cemtrex met on February 7, 2023. Cemtrex effected a 1-for-35 reverse stock split that took effect at 12:01 a.m. Eastern Standard Time on January 25, 2023, and reflected with the Nasdaq Capital Market and in the marketplace at the open of business on January 25, 2023, whereupon the shares of common stock began trading on a split-adjusted basis. In connection with the reverse split, the Company's common stock continues trading on Nasdaq under the symbol "CETX" but now trades under a new CUSIP Number, 15130G 709.

09:04 EST OceanPal announces delivery of Panamax dry bulk vessel m/v Melia - OceanPal announced that, through a separate wholly-owned subsidiary, it has taken delivery of the m/v Melia, a 2005 built Panamax dry bulk vessel of 76,225 dwt that the Company entered into an agreement to purchase in early February 2023. OceanPal Inc.'s fleet currently consists of 5 dry bulk vessels.

09:03 EST Backblaze receives SOC 2 Type 2 certification - Backblaze received a System and Organization Controls 2 Type 2 successful report after completing a SOC 2 examination of the infrastructure and operating effectiveness of controls by an independent third-party auditing firm.

09:02 EST Steel Dynamics names Barry Schneider COO - Steel Dynamics appointed Barry Schneider to the newly created position of President and COO, effective March 1. Schneider, a 28-year veteran of the company, has been its Senior VP, Flat Roll Steel Group, since March 2016. Before that, Schneider served in various operational and leadership roles within the company's steel operations.

09:02 EST Lucid Group announces $7,500 EV credit on purchase of select Lucid Air models - Lucid Group announced that customers can receive a $7,500 EV credit on the purchase of the award-winning Lucid Air. Starting Feb 9,, this limited time offer is available for select configurations of Lucid Air Touring and Air Grand Touring models purchased by March 31.

08:51 EST Recruiter.com, hireEZ partner to enhance talent acquisition efficiency - Recruiter.com Group announced a strategic partnership with hireEZ. With hireEZ's technology and Recruiter.com's extensive network of OnDemand recruiters working together, both organizations aim to provide the recruitment industry with an elevated level of efficiency and effectiveness when hiring talent.

08:50 EST Kellogg working towards N.A. cereal spin-off, to retain plant-based business - Kellogg Company said it continues to work towards its previously announced spin-off of its North America cereal business by year end. After exploring strategic options, the company has decided to retain its plant-based business, which represents 2% of net sales and "offers strong long-term growth prospects."

08:49 EST DermTech: GSA recommends foundational assay included in DMT for VHA coverage - DermTech announced that U.S. General Services Administration has recommended the Company's foundational assay included in the DermTech Melanoma Test or DMT for coverage by the Veterans Health Administration VHA . The VHA is the largest integrated health care system in the U.S. providing care at 1,298 health care facilities. This coverage recommendation makes the foundational assay of the DMT available to the VHA's over 9 million enrolled Veterans. The DMT is an innovative, non-invasive way to enhance melanoma detection with a greater than 99 percent negative predictive value NPV . "We're honored to join the VHA in bringing our non-invasive melanoma test to America's Veterans," said Dan Visage, senior vice president of payor access, DermTech. "The DMT test results are clinically meaningful and actionable, improve patient care and reduce healthcare costs. We look forward to teaming up with the VHA to make our test widely available to its beneficiaries in the coming months." DermTech's total covered lives in the U.S. are now approximately 124M, which includes 68M for Medicare/Medicare Advantage and 56M for commercial and governmental payers.

08:48 EST Blink Charging signs 10-year agreement with BluePoint to deploy 280 EV chargers - Blue Corner, a Blink Charging Company, announced it has signed a 10-year agreement with BluePoint, a leading venue and workspace provider and subsidiary of Belgium's Technology Trade Federation AGORIA, to deploy 280 EV charging ports to support more than 2,000 member companies at BluePoint's business & network centers throughout Belgium. Blue Corner will install, operate, and maintain the new EQ 200 EV chargers at selected BluePoint business & conference centers located in Brussels, Antwerp and Liege. The installation of the fast Level 2 chargers will be phased in over the next couple years, providing much needed charging services to meet the increasing demand as EV sales continue to grow throughout Belgium.

08:46 EST Yoshiharu introduces special menu items for Valentine's Day - Yoshiharu Global announced the launch of its Valentine's Day special menu items and promotion, which will be available from February 11-14, 2023 in all restaurant locations. The Valentine's Day special menu items will feature Lobster Ramen as well as Yoshiharu's new signature dish, the Tonkotsu Crispy Ramen with Spicy Tuna Lobster. For a limited time, customers can try a combination plate which includes both new selections for $45. Following the end of the promotion period on February 14, 2023, the Lobster Ramen and Tonkotsu Crispy Ramen with Spicy Tuna Lobster will each be sold individually.

08:44 EST GSR II Meteora Acquisition announces filing of definitive proxy statement - GSR II Meteora Acquisition and Lux Vending, LLC dba Bitcoin Depot announced that GSRM filed a definitive proxy statement with the U.S. Securities and Exchange Commission in connection with GSRM's Special Meeting of Stockholders to, among other things, approve the previously announced proposed business combination with Bitcoin Depot. The Special Meeting of GSRM's stockholders will be held virtually at www.cstproxy.com/gsrmet/2023 on March 30, 2023 at 10:00 a.m. Eastern Daylight Time. Mailing of the Proxy Statement to GSRM's stockholders of record as of the close of business on February 3, 2023 commenced on February 8, 2023. Before making any voting or investment decision, investors and security holders of GSRM are urged to carefully read the entire Proxy Statement and related proxy materials, and other documents filed in connection with the Business Combination with the SEC, because they contain important information about the Business Combination and the related stockholder proposals. Upon closing of the Business Combination, which is expected to occur shortly after the Special Meeting, and subject to the terms of the business combination agreement, the combined company will be named Bitcoin Depot Inc. and trade on the Nasdaq under the ticker symbol "BTM."

08:43 EST Edible Garden announces research partnership with NJIT, USDA, EPA - Edible Garden AG announced a research partnership with the New Jersey Institute of Technology, NJIT, the United States Department of Agriculture, USDA, and the Environmental Protection Agency, EPA, studying the impacts of nanobubble technology on food safety of fresh produce and processing procedures. Jim Kras, Chief Executive Officer of Edible Garden, commented, "We are excited about joining forces with NJIT, USDA, and EPA in this research partnership, as their commercial partner. The EPA funded partnership will focus on studying the use of nanobubble technology in a CEA environment. Nanobubbles are tiny bubbles of gas, smaller than traditional bubbles, believed to improve plant growth and crop yields in soil-based and hydroponic systems. The research will aim to validate the potential benefits of nanobubbles for indoor agriculture and explore their impact on plant health, water usage, nutrient utilization, and energy efficiency. We believe that this research is well-aligned with our Zero-Waste Inspired philosophy. Nanobubble technology has the potential to revolutionize plant nutrition, providing more nutritious plants with longer shelf lives, which could greatly benefit Edible Garden's products."

08:42 EST Ameresco teams with Alton, Illinois to develop and install 5MW solar array - Ameresco announced its partnership with the City of Alton, Illinois to develop and install a 5 megawatt AC /7 megawatt DC or ,MWDC, solar array. The solar installation will be developed on a local closed municipal landfill site in the city..."Once completed, this solar array is expected to provide the City of Alton with substantial revenue from clean energy generation while also making beneficial use of a previously un-usable brownfield site," said Jon Mancini, Senior Vice President of Solar Project Development at Ameresco. "We're honored to have been selected as partners on this project, and look forward to installing a state-of-the-art solar array designed to provide a great benefit to the local community through meaningful progress toward meeting the city's clean energy goals." Construction is slated to begin in the spring of 2023 and is expected to reach completion by the end of the year.

08:41 EST Minim to enhance user experience with launch of Support+ on motosync app - Minim announced the launch of Support+, an upcoming premium support subscription that offers a greatly enhanced end-to-end customer support experience. Launching in June of 2023, the Support+ subscription costs $36.99 annually for full access to the enhanced support experience. Recent data collected by Minim reveals that users reported nearly 40% of all support tickets over the last year through in-app chat support. "The Minim solution powers over a million networks through the motosync mobile app, so providing an excellent user experience is our top priority," said Minim CEO Mehul Patel. "We're thrilled to offer our app users a subscription that provides expert customer support engineered for them. Support+ our latest product to help our users do more and live better with connectivity."

08:39 EST Vita Coco to deliver free hangover recovery after the Big Game - Vita Coco's (COCO) digital storefront, The Hangover Shop, and local commerce platform DoorDash (DASH), are teaming up to provide free hangover essentials for DashPass members nationwide, up to $15 off. Starting Monday, February 13, Vita Coco and DoorDash are launching The Hangover Shop for consumers nationwide, after piloting the one-stop-shop in select markets in 2022. The Monday after the Big Game marks The Hangover Shop's first nationwide expansion with DoorDash.

08:37 EST Joby completes 2nd stage requirement for FAA commercial certification of eVTOL - Joby Aviation announced it has completed the second of five stages required by the Federal Aviation Administration, FAA, to certify its electric vertical take-off and landing, eVTOL, aircraft for commercial passenger use...Joby believes it is the first eVTOL company to reach this milestone, having also been the first eVTOL company to complete stage one and have its Certification Basis published in the Federal Register. Achieving this goal moves Joby one step closer to its target of launching commercial passenger service by 2025. "Certification is an integral part of everything that an aerospace company does and with the achievement of this critical milestone, we're now able to confidently focus our efforts on closing the remaining certification plans and completing the testing required to certify our aircraft," said Didier Papadopoulos, Head of Aircraft OEM at Joby.

08:34 EST Sabre, Simplenight announce strategic technology agreement - Sabr and Simplenight announce a multi-year strategic technology agreement. Simplenight, a B2B omnichannel commerce platform, provides customized booking solutions and extensive travel content across more than 30 categories such as air, lodging, car, tours, attractions, events, and dining to an extensive network of demand partners. Under the agreement, Simplenight will benefit from Sabre's extensive travel ecosystem including its wide geographic scope and breadth of travel content, which includes air, lodging, ancillary and NDC content. In addition, Simplenight will exclusively utilize Sabre Virtual Payments as its B2B payment provider, bringing them payment flexibility and control, increased fraud protection and security, accurate reconciliation and better automation and efficiency.

08:22 EST SOBR Safe appoints Chris Burton as director of commerical development - SOBR Safe announced the hiring of Chris Burton, Director of Commercial Development. Chris is introducing SOBRsafe to the $8B U.S. telematics market through established industry relationships - which include original equipment manufacturers Daimler, Freightliner, Continental and Thomas Built Buses. Prior to SOBRsafe, Chris was an Enterprise Sales Director for prominent telematics provider Zonar Systems.

08:21 EST SeaStar Medical receives FDA approval to begin study with SCD - SeaStar Medical announces that the U.S. Food and Drug Administration, FDA, approved the Company's investigational device exemption, IDE, application to conduct a pivotal study evaluating the effectiveness of its Selective Cytopheretic Device, SCD, in reducing hyperinflammation in adults with acute kidney injury (AKI) requiring continuous kidney replacement therapy, CKRT. The Company plans to begin enrollment in this 200-patient randomized, controlled trial in March 2023. We currently expect to generate interim study results during the fourth quarter of 2023 and topline study results and submission of a Pre-market Approval, PMA, application in the second half of 2024. The study's primary endpoint is a composite of 90-day mortality and dialysis dependency of patients treated with SCD in addition to CKRT standard of care, compared with the control group receiving CKRT standard of care. "We are excited about the potential of SCD to treat life-threatening hyperinflammation in severely ill patients with AKI requiring CKRT. With approval to begin the pivotal study, we are one step closer to bringing this potentially lifesaving therapy to nephrology and critical care professionals and the adult patients they treat," said Kevin Chung, MD, Chief Medical Officer of SeaStar Medical. "We are eager to enroll participants quickly as we continue our rigorous evaluation of the SCD's safety and effectiveness. We believe the SCD has the potential to change the way we treat patients who need CKRT in the ICU while saving lives along the way."

08:19 EST IntelGenx enters research collaboration with Per Svenningsson - IntelGenx announced a research collaboration with Per Svenningsson, MD, PhD, of the Karolinska Institute, to plan and conduct a multicentre, randomized, double-blind, placebo-controlled clinical study to investigate the use of IntelGenx's Montelukast VersaFilm for the treatment of Parkinson's Disease. Dr. Svenningsson will serve as the Principal Investigator for the planned Study and will sponsor it through a 20 million Swedish Crowns grant awarded by the Swedish Research Council, Sweden's largest governmental research funding body. IntelGenx will supply Dr. Svenningsson with both active and placebo films to be used in the 18-month treatment regimen for study participants. Upon completion of the Study, IntelGenx will retain the intellectual property rights and use the findings to further develop its Montelukast VersaFilm program for Parkinson's disease treatment. The Study is currently expected to commence in the third quarter of 2023.

08:17 EST Cognition Therapeutics completes enrollment of CT1812 Phase 2 SEQUEL study - Cognition Therapeutics announced that enrollment has completed in the randomized, double-blind Phase 2 SEQUEL study of CT1812 in 16 adults with mild-to-moderate Alzheimer's disease. The study was designed to assess differences in synaptic function in CT1812- versus placebo-treated participants using quantitative electroencephalogram to measure theta waves, the type of brain activity most commonly associated with processing information and memory formation. Topline results from SEQUEL are expected mid-2023. "We have previously shown that qEEG can detect changes in whole-brain electrical patterns as well as regional patterns associated with the coordinated transfer of information that is required for executive function in Alzheimer's disease," explained Everard (Jort) Vijverberg, M.D., Ph.D., a neurologist and senior researcher at the Amsterdam University Medical Centers and principal investigator in SEQUEL. "In the SEQUEL study, we use qEEG as an experimental outcome measure to determine the effect of CT1812 on Alzheimer disease processes in the brain. We expect results will show that untreated Alzheimer's patients experience an increase in theta power and a decrease of the alpha band, which may indicate a slowing of brain activity."

08:16 EST BTCS engages Baker McKenzie to investigate German exchange listings - BTCS announced that it has engaged Baker McKenzie, specifically their Frankfurt Office, a renowned law firm, to investigate the listing of its shares on five German stock exchanges as well as three other German trading venues. The move comes in response to serious concerns raised by investors over the lack of transparency and potentially detrimental effects on our share price on the Nasdaq, our primary market. Charles Allen, CEO of BTCS, emphasized the Company's commitment to protecting its investors, particularly its over 35,000 retail investors. "Shares with primary listings outside the European Union, including BTCS, are not protected by EU Regulations on Short Selling, which prohibits, among other things, naked short sales which would otherwise be illegal in both the United States and EU." Allen continued "Our goal is to ensure that our securities trade in fair and transparent markets, and we are taking all necessary steps to achieve that. We did not apply or agree to have our shares traded on these exchanges, and we believe it is important to take action to get delisted and address our investors' concerns.... Baker McKenzie is a global law firm with over 6,500 lawyers in more than 70 offices. For more than 70 years, they have helped clients solve their most complex legal challenges and achieve their business goals. With this level of experience and expertise, they are uniquely positioned to help us investigate our listing on these exchanges and provide assistance in getting delisted." continued Allen.

08:15 EST Kiora Pharmaceuticals received IND approval for Phase 2 study of KIO-101 - On February 7, 2023, Kiora Pharmaceuticals issued a press release announcing that it has received investigational new drug application approval for a Phase 2 study of KIO-101 for the treatment of the Ocular Presentation of Rheumatoid Arthritis or other autoimmune diseases, or OPRA+. This study will enroll approximately 120 patients in a multi-center, controlled, randomized, double-masked trial assessing the safety and efficacy of KIO-101 eye drops in patients living with autoimmune disease who have signs and symptoms of ocular surface disease. The study is expected to begin enrolling patients in Australia in the first half of 2023.

08:14 EST GlobalFoundries acquires Renesas' non-volatile resistive RAM technology - GlobalFoundries (GFS) announced that it has acquired Renesas Electronics Corporation's (RNECY) proprietary and production proven Conductive Bridging Random Access Memory technology, a low power memory solution designed to enable a range of applications in home and industrial IoT and smart mobile devices. The transaction further strengthens GF's memory portfolio and extends its roadmap of embedded non-volatile memory solutions by adding another reliable, customizable embedded memory solution that is relatively easy to integrate into other technology nodes. Specifically, this technology will enable customers to further differentiate their SoC designs and advance a new generation of secure and intelligent devices. CBRAM's low power consumption, high read/write speeds, reduced manufacturing costs and tolerance for harsh environments make it particularly suitable for consumer, medical, and select industrial applications. In 2020, GF entered into a licensing agreement with Dialog Semiconductor, which was acquired by Renesas in 2021, to offer its CBRAM technology as an embedded, NVM option.

08:14 EST PowerFleet expands partnership with Energisa - Powerfleet expands its partnership with Energisa, the fifth largest electricity distribution group in Brazil. Following its successful rollout of Powerfleet's fleet management solution, Energisa will continue improving vehicle fleet operations with Unity, Powerfleet's fleet intelligence platform. The relationship exemplifies the rapid growth and capabilities of Powerfleet throughout Brazil and the broader South American market. "Our customers are at the heart of what we do at Powerfleet," said Pablo Porto, General Manager for Brazil and Argentina, Powerfleet. "We strive to give executives and fleet managers peace of mind about the safe and efficient use of their vehicles, as well as providing a true partnership that expands as they grow. Playing a key role in Energisa's digital journey epitomizes this. Unity provides a single source for data intelligence, enabling Energisa to offer efficient services to customers, keep their workforce safe, and reduce operational costs." To improve driving behavior and safety, Energisa created the 'Conscious Driving Project.' This is based on self-management of driving habits, powered by real-time alerts from Powerfleet. Unity's data insights enable Energisa to analyze driving performance over time to create individual driver scorecards and economy ratings. Additionally, Energisa uses Powerfleet to increase fuel economy through reduction of idling, harsh breaking, and rapid acceleration.

08:13 EST Skylight Health provides corporate update, strategic priorities - Skylight Health Group provides the following business updates and strategic priorities. Value-Based Care: First Full Year Contribution: 2023 marks the first year of the Company's participation in the ACO Reach program through its joint venture with Centene/Collaborative Health Systems. As part of this participation, the Company's traditional aligned Medicare members will move into a capitated full risk model similar to its current Medicare Advantage at risk programs in Florida. The Company will receive improved funding through the program to support its members with additional resources to support their care including care coordination, community support and improved access. Value-Based Care: Membership Growth: Based on exit 2022 estimates, the Company has enrolled 849 traditional Medicare members into the ACO Reach Along with its MA at risk members both through owned and affiliate practices, this brings the total membership at risk to 3,736. The Company expects that growth in 2023 will come organically from new membership, new plans and improved performance against current benchmarks. The Company has already seen efforts in areas of patient care coordination and accurate coding leading to positive savings and revenue growth trends for 2023. Electronic Health Record Roll-Out: Skylight has also begun the rollout of Athena, the electronic health record platform chosen by the Company for a national standard across its practices, in the NeighborMD practices. This is the last remaining group to join the centralized system. Financial Improvements: Skylight continues to work through its rigorous turnaround plan initiated in early 2022. Efforts made in 2022, have positively impacted adjusted EBITDA with previously reported results in Q3, 2022 to show an improvement of approximately 68%. The Company expects to continue positively impacting this trend through 2023 and is working towards adjusted EBITDA profitability in 2023.

08:12 EST DZS expands AI-enabled Cloud EDGE solutions suite - DZS expanded its Artificial Intelligence-enabled Cloud EDGE solutions suite to include a cloud hosted service offering. The new DZS Xperience Cloud is a multi-tenant managed service offering targeting regional and rural communications service providers and fiber overbuilders that want to deliver their subscribers superior WiFi management and service assurance, while enjoying all the cost and risk advantages of a managed service approach.

08:10 EST Immix Biopharma's Nexcella presents interim data from NEXICART-1 study - Nexcella announced updated clinical data from its ongoing Phase 1 NEXICART-1 study of its novel, autologous, BCMA-targeted chimeric antigen receptor T cell therapy NXC-201 for the treatment of patients with relapsed or refractory multiple myeloma and light chain amyloidosis. The dataset represents 22 new evaluable patients in relapsed or refractory multiple myeloma and one new evaluable patient in AL. The new data are being presented during a poster presentation at the European Society for Blood and Marrow Transplantation and European Hematology Association 5th European CAR T-cell Meeting to be held in Rotterdam, Netherlands February 9-11, 2023. As of the data cutoff of October 23, 2022, 42 multiple myeloma patients were evaluable for efficacy and safety. These patients comprised the dose escalation cohorts for the first dose level, the second dose level, and a dose expansion cohort at the recommended Phase 2 dose of 800 million CAR+T cells. This dataset represents 22 new evaluable patients in relapsed or refractory multiple myeloma at the NXC-201 RP2D. The interim NXC-201 data demonstrate potentially meaningful efficacy and durable responses in relapsed or refractory patients who have a poor prognosis. Of the 42 evaluable patients across all dose levels with median follow-up of 146 days: 35 of 42 overall response rate was achieved per International Myeloma Working Group criteria; 21 of 42 patients achieved complete response or a stringent complete response; 34 of 42 patients achieved greater than very good partial response; 1 of 42 patients achieved a partial response;Improved outcomes were observed in the 29 relapsed or refractory multiple myeloma patients receiving the therapeutic dose of NXC-201: 90% ORR was achieved per International Myeloma Working Group criteria; 17 of 29 patients achieved CR or sCR; 25 of 29 patients achieved greater than VGPR; 1 of 29 patients achieved a PR; NXC-201 continues to be well-tolerated. Of the 42 evaluable patients: No cases of immune effector cell-associated neurotoxicity syndrome; Low-grade CRS duration of median 2 days was observed, with the vast majority of CRS events starting on the day of infusion

08:09 EST Ametek raises quarterly dividend to 25c from 22c per share - The dividend is payable on March 31 to shareholders of record as of March 10.

08:07 EST Nuvectis Pharma announces publication in JEM for NXP900 - Nuvectis Pharma announced a publication in the Journal of Experimental Medicine, JEM, for NXP900 in an in-vivo model of metastatic castration resistant prostate cancer, mCRPC, with acquired resistance to enzalutamide, the active ingredient in XTANDI. "This publication adds encouraging new data to the substantial body of evidence supporting the clinical potential of NXP900," said Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis. Bentsur continued, "Led by top scientists and published in a leading scientific journal, the research, which highlights NXP900's potential to reverse XTANDI resistance when dosed in combination with XTANDI, also highlights the relationship between the effects seen in the enzalutamide-resistant mCRPC model to NXP900's mechanism of action. Based on all the evidence generated to date, we believe that NXP900 has the potential to become a best-in-class SRC/YES1 kinase inhibitor with potential utility in a range of solid tumor cancers and we look forward to unlocking its therapeutic potential in the clinic."

08:06 EST Absci partners with SJCI to expedite development of cancer therapies - Absci Corporation and St. John's Cancer Institute, SJCI, a pioneer in cancer care, research and innovation, today announced they have entered into a partnership to uncover breakthrough cancer therapies. This partnership will leverage Absci's Integrated Drug Creation platform, which combines cutting-edge generative AI models and proprietary wet-lab technologies and SJCI's leading cancer biospecimen repository and molecular database to identify at accelerated speeds new therapeutic candidates with the potential for higher probability of clinical success. "St. John's Cancer Institute has pioneered advances in cancer immunotherapy for decades and built one of the largest cancer tissue specimen biorepositories in the United States," said Sean McClain, Founder and CEO of Absci. "Currently, it takes about ten years and costs over $1 billion to bring one drug to market for patients. The combination of our generative AI platform and SJCI's large biorepositories and related molecular analysis database can accelerate the development of better biologics for patients, faster." Through the partnership, Absci will integrate SJCI's extensive clinically annotated molecular data assets into Absci's target discovery platform. The novel targets will be screened and assessed for parameters important to drug development and for functional and mechanistic validation using Absci's industry-leading AI capabilities, catalyzing and accelerating SJCI's discovery and development of promising cancer drug targets and therapies.

08:05 EST Amarin urges shareholders to vote 'AGAINST' all of Sarissa's proposals - Amarin Corporation announced that it has mailed a letter to shareholders in connection with the General Meeting of Shareholders urging shareholders to vote "AGAINST" all proposals on the WHITE proxy card. The General Meeting of Shareholders is scheduled to be held on February 28, 2023, and shareholders of record as of January 23, 2023, will be entitled to vote at the meeting. "1. We are a NEW Amarin: NEW Board, NEW Management Team and NEW Strategy. The Amarin of today is a profoundly different company than 18 months ago. We recognized change was needed, and today, this new team is executing a turnaround strategy to drive value with the oversight of a purpose-built Board. Amarin is making early progress. Now is the time for us to build on our momentum to turn the Company around and create value for our shareholders. It is not the time to remove our new, highly qualified Chairman, Per Wold-Olsen, nor is it the time to nearly double the size of the Board with underqualified candidates as part of Sarissa's self-serving attempt to get on the Board. 2. Sarissa has a track record of value destruction. Sarissa claims it has created value in the healthcare space, but the facts show the opposite... 3. Amarin has the right Board and team to maximize shareholder value. We don't need Sarissa to do it. When it comes to M&A, you should know that the Amarin Board is committed to evaluating any real opportunity that would maximize value for Amarin shareholders, including a sale of the Company. We specifically added M&A expertise to our Board - Adam Berger, who has extensive experience as a healthcare investment banker, including involvement in over 90 sales - as well as directors and a leadership team with extensive backgrounds at and relationships with large global pharma companies. Simply put, we don't need Sarissa to maximize value..."

08:03 EST Teledyne Geospatial releases Galaxy Onboard solution - Teledyne Geospatial announced the release of the Galaxy Onboard, a workflow-focused solution that enables airborne surveyors to deliver quality-controlled processed data in real time. With Galaxy Onboard, Teledyne Geospatial has lowered the barrier of entry for organizations venturing into airborne mapping with a solution that does not require expertise or months of training.

07:58 EST Oramed exploring strategic alternatives - Oramed's management and Board of Directors are examining the company's existing pipeline and conducting a comprehensive review of strategic alternatives. As part of this review process, Oramed will explore potential strategic alternatives that may include, but are not limited to, an acquisition, merger, business combination, or other transaction. Oramed has not set a timetable for completion of this review process. There can be no assurance that this process will result in any such transaction and the company does not intend to disclose additional details unless and until it has entered into a specific transaction. In addition, continues to conduct a comprehensive analysis of the data from its discontinued Phase 3 oral insulin trials.

07:50 EST AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis - In Q4: Global Humira net revenues of $5.579 billion increased 4.6 percent on a reported, or 6.0 percent on an operational basis. U.S. Humira net revenues were $5.006 billion, an increase of 9.9 percent. Internationally, Humira net revenues were $573 million, a decrease of 26.5 percent on a reported basis, or 16.9 percent on an operational basis. Global Skyrizi net revenues were $1.576 billion, an increase of 76.1 percent on a reported basis, or 78.9 percent on an operational basis. Global Rinvoq net revenues were $770 million, an increase of 49.0 percent on a reported basis, or 55.4 percent on an operational basis.

07:48 EST Athene announces $2B close for Apollo/Athene Dedicated Investment Program II - Athene Holding announced a first close for Apollo / Athene Dedicated Investment Program II with approximately $2B in capital commitments. ADIP II is the second vintage of the innovative sidecar program formed to augment Athene's growth capacity through long-term, on-demand capital. Funds from ADIP II will be invested directly alongside Athene into Athene Co-Invest Reinsurance Affiliate Holding 2, a consolidated subsidiary of Athene, which is managed to the same risk, investment, and capital standards as Athene.

07:47 EST UK court rules in favor of Interdigital in patent litigation with Lenovo - InterDigital (IDCC) announced that a UK court has once again ruled in its favor in the company's patent litigation with Lenovo(LNVGY). The Court of Appeal in London overturned the High Court's ruling on invalidity, finding that InterDigital's patent is valid and upheld the High Court's ruling that the patent is essential and infringed. This is the third court victory for InterDigital in this dispute since the beginning of 2023. In January, the Court of Appeal upheld a lower court verdict that an InterDigital cellular patent is valid, essential and infringed and, in the third technical trial, the High Court ruled that Lenovo is infringing another InterDigital cellular patent, which was also deemed to be valid and essential. A decision is pending in a separate trial to determine fair, reasonable and non-discriminatory terms for a license to InterDigital's portfolio.

07:41 EST MSG Entertainment provides update on spin-off of live entertainment business - The Company also recently announced that it is moving forward with the spin-off of its traditional live entertainment business. In January, the company confidentially submitted an Amended Form 10 Registration Statement with the SEC for the proposed transaction and anticipates filing a publicly available Form 10 Registration Statement with the SEC this month. In addition, the company expects to complete the spin-off by the end of March. Completion of the transaction remains subject to various conditions, including final Board approval.

07:41 EST Canopy Growth announces additional cost reduction program - Canopy Growth announced that it is transitioning to an asset-light model in Canada by exiting cannabis flower cultivation in the company's Smiths Falls, Ontario facility, ceasing the sourcing of cannabis flower from the Mirabel, Quebec facility, and moving to a third-party sourcing model for cannabis beverages, edibles, vapes, and extracts. These changes come in addition to multiple cost reduction activities within FY2023, including the divestiture of Canopy Growth's Canadian retail operations, the organizational restructuring of certain corporate functions, and the closure of the Scarborough, Ontario research facility. As a result of the cost reduction initiatives undertaken in fiscal 2023, the company intends to close its 1 Hershey Drive facility in Smiths Falls, Ontario, in addition to reducing headcount across the business by approximately 60%, including 800 positions impacted by the changes announced today, of which 40% are impacted immediately. Management expects these cost reduction initiatives will reduce annual Cost of Goods Sold and Selling, General & Administrative expenses by a combined C$140-C$160 million over the next 12 months, bringing the total cost reduction target to C$240-C$310 million inclusive of the reductions announced in April 2022. Canopy Growth continues to progress its U.S. strategy through Canopy USA, and is committed to remaining dual-listed on the TSX and the Nasdaq. Based on our current revenue run rate and these cost reduction initiatives, management reaffirms its expectation to achieve positive Adjusted EBITDA in FY2024, with the exception of investment in BioSteel.

07:39 EST Repligen appoints Martin Madaus to board of directors - Repligen (RGEN) announced the appointment to its Board of Directors of life sciences tools industry leader Martin Madaus. Madaus is currently a senior operating executive at The Carlyle Group (CG). In addition to his current public company board positions, Dr. Madaus currently leads the boards of three private companies - Unchained Labs, Emulate, Inc. and UltiVue Inc.

07:37 EST Kura Oncology announces first patients dosed in Phase 2 trial of ziftomenib - Kura Oncology announced that the first patients have been dosed in its KOMET-001 Phase 2 registration-directed trial of ziftomenib, the Company's novel menin inhibitor, in patients with NPM1-mutant relapsed or refractory acute myeloid leukemia, AML. "Dosing the first patients in our registration-directed trial of ziftomenib marks a significant milestone for our menin inhibitor program," said Troy Wilson, Ph.D., J.D., President & Chief Executive Officer of Kura Oncology. "Building on the strength of our Phase 1 data, we remain committed to our mission to realize the full potential of ziftomenib as an important treatment option to patients with acute leukemia. The speed with which we have begun enrolling in this registration-enabling Phase 2 study speaks to the significant interest in ziftomenib among investigators."

07:36 EST Soligenix implementing 1-for-15 reverse stock split - Soligenix intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 15 pre-split shares. The reverse stock split will become effective at 4:00 p.m. on Thursday, February 9. Soligenix's common stock will continue to be traded on Nasdaq under the symbol SNGX and will begin trading on a split-adjusted basis when the market opens on Friday, February 10. The new CUSIP number for the Company's common stock following the reverse stock split will be 834223505. Every 15 shares of Soligenix's issued and outstanding common stock will be converted automatically into one issued and outstanding share of common stock without any change in the par value per share. The reverse stock split will affect all stockholders uniformly and will not alter any stockholder's percentage interest in the company's equity, except to the extent that the reverse stock split would result in a stockholder owning a fractional share. Any fractional share of a stockholder resulting from the reverse stock split will be rounded up to the nearest whole number of shares. The reverse stock split will reduce the number of shares of Soligenix's common stock outstanding from 43,335,174 shares to approximately 2,889,012 shares.

07:27 EST Laser Photonics announces plans for next generation CleanTech laser systems - Laser Photonics announced plans for expanding the target market for its next generation CleanTech portfolio with utility-grade lasers systems. Wayne Tupuola, CEO, commented, "With the country's aging infrastructure and increasing electrical demands, the cost of inspection and maintenance of electrical utility installations are at an all-time high. Today, the cleaning of insulators and clearing electricity lines from debris are currently carried out manually by operators using scaffolds, ropes and even helicopters. Our goal is to develop a CleanTech system specific for these utility applications, aiming to reduce the cost and risk associated with today's processes that can be safely operated on the ground, by a single technician, providing a safer, greener and more cost-effective solution to utility companies. When combined with our roadmap to integrate IoT solutions, we believe utilities will also be able to remotely monitor crucial KPIs across all business lines."

07:25 EST Electrovaya receives $3.4M battery order for MHEVs - Electrovaya announced the receipt of a battery purchase order through its OEM sales channel valued at approximately US$3.4M. The batteries will be used by a leading Fortune 100 retailer to power Materials Handling Electric Vehicles in the United States. Deliveries will be made during the 2023 fiscal year.

07:21 EST SweetWater announces 420 Fest 2023 lineup, venue - SweetWater Brewing Company announces details for this year's SweetWater 420 Fest, which will take place on April 22-23, 2023 at SweetWater's Atlanta brewery. The 17th annual festival will be headlined by Shakey Graves, Pigeons Playing Ping Pong, Ghostland Observatory, Rome & Duddy, and Neal Francis.

07:20 EST Interpublic Group board raises quarterly dividend 7% to 31c per share - Interpublic Group announced that the company's Board of Directors has declared a quarterly dividend on IPG common stock of $0.31 per share, payable on March 15, 2023, to holders of record at the close of business on March 1, 2023. The increase in the dividend from $0.29 to $0.31 per share represents a seven percent increase to the Company's quarterly dividend.

07:19 EST Trisura Group reschedules release of Q4, FY22 results - Trisura Group will reschedule the release of its fourth quarter and full year 2022 results, previously scheduled for Thursday, February 9th, 2023. Trisura expects to release its fourth quarter and full year 2022 results in February 2023. Details regarding the date and time of Trisura's earnings release and conference call with be announced separately once confirmed. The delay is necessary for Trisura to finalize the accounting treatment and review of certain contracts and related information for its US subsidiary.

07:13 EST AST SpaceMobile announces collaboration with Saudi Arabia-based Zain KSA - AST SpaceMobile announced a non-binding memorandum of understanding, MoU , with Zain, a telecommunications operator and a digital service provider in Saudi Arabia. The signing took place at the international LEAP 2023 Tech Conference in Riyadh. The MoU would enable AST SpaceMobile and Zain KSA to collaborate towards new telecom solutions and satellite-based digital services in Saudi Arabia and aim to increase access to mobile services in remote locations, including on land, at sea and in flight. "We are thrilled to cooperate with Zain in Saudia Arabia. We hope this collaboration will further access to reliable, space-based cellular broadband for current and future mobile users in the country," said Chris Ivory, Chief Commercial Officer of AST SpaceMobile. We are committed to expanding our digital services and communications to deliver an inclusive ecosystem that covers the whole Kingdom with the highest service quality and reliability, thereby enhancing our role in achieving a more connected and sustainable world," said Eng. Abdulrahman Al-Mufadda, Chief Technology Officer of Zain KSA. "We are confident that our collaboration with AST SpaceMobile, could help to potentially provide space based cellular broadband connectivity in the Kingdom, particularly in remote areas. In doing that, we reaffirm our commitment to ensuring that every citizen and resident in this precious land is connected wherever they may be."

07:12 EST Interpublic Group board raises quarterly dividend 7% to 31c per share - Board approves 7% dividend increase to $0.31 per share per quarter and additional authorization amount of $350M to share repurchase program.

07:12 EST Verano Holdings to open MUV Orlando Colonial - Verano Holdings announced the opening of MUV Orlando Colonial on Friday, February 10, the Company's 64th Florida dispensary and 122nd nationwide. MUV Orlando Colonial is the third MUV retail location in Orlando, complementing existing dispensaries that are situated on Garland Avenue and Vineland Avenue. "We're thrilled to open another convenient MUV dispensary to provide the growing Orlando medical cannabis community with access to our suite of premium cannabis products," said John Tipton, President of Verano. "With three MUV dispensaries in the Orlando area, our compassionate team of cannabis advisors are ready and eager to serve the local patient community for years to come."

07:10 EST Elys Game Technology partners with T & L Hospitality - Elys Game Technology announces that the Company has entered into an agreement with T & L Hospitality to operate a sportsbook at a venue which could in the future be repurposed as a sportsbook within a hotel situated at 2700 New York Avenue NE in Washington, DC. "We are thrilled to partner with T & L Hospitality to operate this exciting new venue in Washington, DC, and being situated along the border of DC and MD, makes this venue accessible to players from both states. We look forward to continuing our sportsbook expansion within restaurants and bars in DC and neighboring states over the coming months," commented Michele Ciavarella, Elys Executive Chairman. "The scaling of this distribution model is strongly gaining momentum in DC with the new JV model implemented as a result of a team effort and consultation with DC regulators. In addition, other jurisdictions such as Ohio and Maryland are quickly adopting this model in an effort to assist local neighborhood business decimated by the pandemic to leverage their loyal customers by providing an interactive on-site sports betting experience, while supplementing their post-pandemic revenue streams. We continue to believe that Elys' distributed model technology architecture and algorithmic trading platform puts us in the enviable position of becoming a market leader as the U.S. and Canada, where, we believe that legislators will continue to accelerate the approval for sports betting in small business venues rather than exclusively through mobile channels. This small-business retail model presents not only an opportunity for neighborhood business entrepreneurs to leverage their established customer relationships, but could also drive economic opportunities in grass roots businesses."

07:08 EST Bitfarms pays off $21M debt obligations for $7.75M in cash - Bitfarms has modified its loan agreement with BlockFi Lending, to settle all outstanding principal and interest due totaling $21M for a single cash payment of $7.75M. On February 18, 2022, Bitfarms' wholly owned US-based subsidiary, Backbone Mining Solutions, entered into a $32M equipment financing facility with BlockFi. BMS owns and operates Bitfarms' 20-megawatt active crypto mining facilities in the State of Washington. At January 31, 2023, outstanding principal and accrued interest on the BlockFi equipment loan facility totalled $21M. On February 8, 2023, BlockFi retired the BMS loan in its entirety and discharged all further obligations for consideration of $7.75M in cash. Subsequent to the settlement, all of BMS' assets, including 6,100 miners, are unencumbered.

07:07 EST Guardforce announces 1-for-40 reverse stock split - Guardforce AI announced that pursuant to the approval of its board of directors and the approval of its shareholders at the Company's extraordinary general meeting held on Tuesday, January 31, 2023 at 11:00 a.m, effected a 1-for-40 reverse stock split of its ordinary shares. On February 2, 2023, Conyers Trust Company Limited, the Secretary of the Company, filed two certificates certifying the ordinary resolutions passed by the shareholders with the Registrar of Companies of the Cayman Islands. The reverse split was consummated upon passing of the ordinary resolutions on January 31, 2023. The Company's ordinary shares are expected to begin trading on the NASDAQ Capital Market on a post-split basis when the market opens on February 10, 2023. No change was made to the trading symbol for the Company's shares of common stock and warrants, "GFAI" and "GFAIW", respectively, in connection with the reverse split. The CUSIP number for the ordinary share following the reverse stock split will be G4236L138. The reverse split will result in every forty shares of Guardforce AI's issued and outstanding ordinary shares of a nominal or par value of US$0.003 each will be automatically converted into one issued and outstanding ordinary share of a nominal or par value of US$0.12 each.

07:06 EST Perella Weinberg Partners board authorizes additional $100M share repurchase - On February 8, 2023, the Firm's Board of Directors authorized the additional repurchase of shares of PWP's Class A common stock in an amount of up to $100 million incremental to the remaining value of approximately $25 million as of February 8, 2023 from February 2022's authorization. The authorization does not require the purchase of any minimum number of shares.

07:04 EST Masco increases quarterly dividend 2% to 28.5c per share - Masco's board of directors declared a quarterly dividend of 28.5c per share, a 2% increase, payable on March 13 to shareholders of record on February 23.

07:01 EST Globus Medical, NuVasive to combine in all-stock transaction

06:46 EST Tempur Sealy increases quarterly dividend 10% to 11c per share - Tempur Sealy announced that its board of directors has declared a first quarter cash dividend on its common stock of 11c per share. The dividend is payable on March 9 to shareholders of record as of February 23.

06:40 EST PepsiCo focused on delivering at least $1B in productivity savings

06:38 EST PepsiCo expects inflationary pressures to persist - In prepared remarks ahead of the Q4 earnings conference call, PepsiCo said: "We plan to mitigate the impact of these pressures by accelerating our productivity initiatives and sharpening our revenue management capabilities. We will also continue to make investments in our people, brands, supply chain, and go-tomarket systems."

06:33 EST Trane raises quarterly dividend 12% to 75c from 67c per share - The dividend is payable March 31 to shareholders of record on March 3.

06:09 EST Precision Drilling sees 2023 CapEx $235M

06:07 EST Hilton reports Q4 system-wide comparable RevPAR up 24.8% - System-wide comparable RevPAR increased 24.8 percent and 42.5 percent, on a currency neutral basis, for the fourth quarter and full year, respectively, compared to the same periods in 2021. System-wide comparable RevPAR increased 7.5 percent and decreased 1.3 percent, on a currency neutral basis, for the fourth quarter and full year, respectively, compared to the same periods in 2019. Approved 24,400 new rooms for development during the fourth quarter, bringing Hilton's development pipeline to 416,400 rooms as of December 31, 2022. Added 17,700 rooms to Hilton's system in the fourth quarter, resulting in 48,300 net additional rooms in Hilton's system for the full year, contributing to net unit growth of 4.7 percent, with fourth quarter hotel openings modestly lagging prior expectations due to the ongoing COVID-19 environment in China.

06:03 EST PepsiCo boosts annualized dividend 10% to $5.06 per share - The company announced a 10% increase in its annualized dividend to $5.06 per share from $4.60 per share, effective with the dividend expected to be paid in June 2023. This represents the company's 51st consecutive annual dividend per share increase.

05:49 EST Meta Platforms completes acquisition of Within - Meta has closed on the acquisition of Within, which makes the subscription fitness app Supernatural. The FTC filed a complaint to stop the deal last year on grounds of Meta building a "virtual reality empire," but Meta won approval last week for the acquisition. Within said via Twitter: "Today marks a new chapter for Within and @GetSupernatural, as we officially join @Meta. We're thrilled to help people transform their lives as we bring more joy, awe and wonder to the world. We look forward to what's ahead." Reference Link

05:45 EST Credit Suisse warns of 'substantial loss before taxes' for 2023 - Credit Suisse said: " In light of the adverse revenue impact from the previously disclosed exit from non-core businesses and exposures as well as, in particular restructuring charges related to our cost transformation, Credit Suisse would also expect the Group to report a substantial loss before taxes in 2023. The Group's actual results will depend on a number of factors including the performance of the IB and WM divisions, the continued exit of non-core positions, any goodwill impairments, litigation, regulatory actions, credit spreads and related funding costs, and the outcome of certain other items, including potential real estate sales. We estimate restructuring expenses for 2023 of CHF ~1.6 bn and 2024 of CHF ~1.0 bn, unchanged from previous guidance . In respect of regulatory capital, the Group continues to target a 2025 pre-Basel III reform CET1 ratio of more than 13.5%, while expecting to maintain a pre-Basel III reform CET1 ratio of at least 13% throughout the transformation period through 2025."

05:44 EST Credit Suisse: Cost transformation 'well under way' - Credit Suisse continues to execute on its strategic transformation at pace and confirms the targets announced at the October 2022 strategy update. The company said: "The actions we are taking are expected to further strengthen liquidity ratios and reduce the funding requirements of the Group. The bank's cost transformation is well under way and actions already initiated by Credit Suisse in 4Q22 are expected to represent ~80% of the 2023 cost base reduction target of approximately CHF 1.2 bn, with further initiatives underway." It added: "Our financial results for 2022 were significantly affected by the challenging macro and geopolitical environment with market uncertainty and client risk aversion. This environment has had an adverse impact on client activity across all our divisions. While we would expect these market conditions to continue in the coming months, we have taken comprehensive measures to further increase our client engagement, regain deposits as well as AuM and improve cost efficiencies."

05:16 EST Addex Therapeutics regains compliance with Nasdaq - Addex Therapeutics announced notification from Nasdaq that it has regained compliance with the minimum bid price requirement of $1.00 per ADS share under Nasdaq Listing Rule 5550 and currently meets all other applicable criteria for continued listing.

05:11 EST ASE Technology reports January revenue $1.48B, down 16.1% - Reports January ATM revenue $798M, down 20%.